Skip to main content
Fresenius SE & Co. KGaA logo

Fresenius SE & Co. KGaA — Investor Relations & Filings

Ticker · FRE ISIN · DE0005785604 LEI · XDFJ0CYCOO1FXRFTQS51 F Human health and social work activities
Open in API
Filings indexed 1,398 across all filing types
Latest filing 2016-12-22 Director's Dealing
Country DE Germany
Listing F FRE

About Fresenius SE & Co. KGaA

https://www.fresenius.com/

Fresenius SE & Co. KGaA is a global healthcare company that provides system-critical products and services for leading therapies for the care of critically and chronically ill patients. The company's portfolio encompasses a wide range of products and services for dialysis, hospitals, and outpatient medical care. Key offerings include intravenously administered generic drugs, biopharmaceuticals, biosimilars, clinical nutrition, and infusion therapies. Additionally, the company operates a large network of private hospitals and outpatient centers. Through its strategic investment in Fresenius Medical Care, it is a leading global provider of products and services for individuals with renal diseases.

Recent filings

Filing Released Lang Actions
DGAP-DD: Fresenius SE & Co. KGaA english
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains a section labeled 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. It details the name of an individual (Dr. Gerd Krick), their position (Member of the administrative or supervisory body), and specific transaction details (Disposal, Price, Volume, Date). This content directly matches the definition for Director's Dealing.
2016-12-22 English
Roadshow Netherlands
Investor Presentation Classification · 98% confidence The document is structured as a presentation, indicated by the 'Agenda' section, slide-like headings (e.g., '# A Leading Global Health Care Group', '## Company Overview'), and the use of bullet points and tables to convey key financial and strategic information. It discusses financial results (Q1-Q3/2016 figures, 2016 outlook), financing facilities, debt structure, and a major acquisition (Quirónsalud). This format strongly suggests an Investor Presentation (IP) or a presentation used during an earnings call or investor day, rather than a formal regulatory filing like a 10-K or a brief Earnings Release (ER). Since it contains detailed financial data, segment breakdowns, and strategic outlooks, 'Investor Presentation' (IP) is the most appropriate classification.
2016-12-20 English
Declaration of Conformity of Fresenius SE & Co. KGaA as of December 20, 2016
Governance Information Classification · 98% confidence The document is explicitly titled as a "Declaration by the Management Board... and by the Supervisory Board... on the German Corporate Governance Code pursuant to Section 161 German Stock Corporation Act (Aktiengesetz)". This type of declaration, which details compliance or non-compliance with specific governance codes (like the German Corporate Governance Code), is a core component of corporate governance reporting. Among the provided definitions, 'Governance Information (Code: CGR)' is the most appropriate fit, as it covers reports detailing the company's internal rules, board structure, and governance practices. The document is a comprehensive statement on governance adherence, not a general announcement (RPA/RNS) or a remuneration report (DEF 14A).
2016-12-20 English
Entsprechenserklärung der Fresenius SE & Co. KGaA vom 20. Dezember 2016
Governance Information Classification · 99% confidence The document is titled "Erklärung des Vorstands der persönlich haftenden Gesellschafterin der Fresenius SE & Co. KGaA, der Fresenius Management SE, und des Aufsichtsrats der Fresenius SE & Co. KGaA zum Deutschen Corporate Governance Kodex gemäß § 161 AktG". This explicitly states it is a declaration regarding the German Corporate Governance Code, as required by § 161 of the German Stock Corporation Act (AktG). This type of declaration details compliance or non-compliance with specific governance recommendations. This aligns perfectly with the definition of Governance Information (CGR), which covers internal rules, board structure, and governance practices, often documented in a Corporate Governance Report or Declaration.
2016-12-20 German
DGAP-DD: Fresenius SE & Co. KGaA english
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains a section header 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. It details transactions (sale of shares following option exercise) by an individual identified as a 'Member of the managing body' of Fresenius SE & Co. KGaA. This content directly matches the definition for Director's Dealing.
2016-12-12 English
Citi Global Healthcare Conference
Investor Presentation Classification · 98% confidence The document text is a presentation titled "# Citi Global Healthcare Conference" dated December 8, 2016. It contains detailed financial highlights, segment performance reviews (Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, Fresenius Vamed), outlook updates, and specific financial tables for Q3/2016. The content structure, including slides, market dynamics, growth drivers, and financial guidance updates, is characteristic of an Investor Presentation (IP) delivered at a conference, rather than a formal regulatory filing like a 10-K or a brief Earnings Release (ER). It is too detailed to be an ER and is clearly a presentation format.
2016-12-08 English

Browse filings by year

31 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.